Two-year disease-free survival from evaluable Phase 2 patients expected by the end of Q1 2028.Strasbourg, France, April 13, 2026, 8:00 a.m. CET – ...
Nektar shares fell $4.14 per share, or 7.77%, closing at $49.16 on December 16, 2025 after trial results revealed four ineligible patients had been enrolled in the pivotal REZOLVE-AA study. The window ...
Two-year disease-free survival from evaluable Phase 2 patients expected by the end of Q1 2028. Strasbourg, France, April 13, 2026, 8:00 a.m. CET - Transgene (Euronext Paris: TNG), a biotech company th ...
ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...
The latest boom in robotics represents a revolution in the way machines have learned to interact with the world.
A research team analyzed linguistic approaches to help cancer patients better comprehend the concept of randomization, being assigned by chance to treatment or control groups, in clinical trials.
BRONCHIECTASIS may silently increase risk of non-tuberculous mycobacteria infection, according to new genetic evidence.
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
A new Moorestown apartment complex is now accepting applications for its affordable housing waiting list, with rents ranging ...
Genetics do play an outsized role in determining your stature, but a new study suggests vitamin D status may also be part of the equation. Here's what you need to know. To better understand whether ...
Antibiotics transform TB care, but without stable health systems, housing improvements, and poverty reduction, the disease ...
Hades 2 Dream Dives shuffle all the regions for a fresh take on the roguelike, but the mode skipped the patch notes for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results